Randomized Trial of a Left Ventricular Assist Device as Destination Therapy Versus Guideline-Directed Medical Therapy in Patients with Advanced Heart Failure. Rationale and Design of the SWEdish Evaluation of Left Ventricular Assist Device (SweVAD) Trial

Abstract

The SweVAD study will compare survival, medium-term benefits, costs and potential hazards between GD-LVAD-DT and GDMT and will provide a valuable reference point to guide destination therapy strategies for patients with AdHF ineligible for HTx.